8 September: Commission launches European Care Strategy

The European Commission has launched a European Care Strategy which aims to ensure quality, affordable and accessible care services across the European Union and improve the situation for both care receivers and the people caring for them, professionally or informally. The Strategy is accompanied by two Recommendations for Member States on the revision of the Barcelona targets on early childhood education and care, and on access to affordable high-quality long-term care.

Read more »
Rate: 12345 (0) | Facebook Twitter
21 September: Check out our World Alzheimer’s Day initiative "What Makes You, You?"

To mark World Alzheimer’s Day this year, we were delighted to launch a new initiative called “What Makes You, You?”, a collaborative effort between Roche, the European Working Group of People with Dementia (EWGPWD) and Alzheimer Europe. It is a series of videos sharing the stories of three members of the EWGPWD, looking beyond an Alzheimer’s diagnosis and celebrating people for who they are.

Read more »
Rate: 12345 (0) | Facebook Twitter
21 September: Our members mark World Alzheimer’s Day

Members news - map of EuropeOur members have been very busy this month, with World Alzheimer’s Day (and month) activities. World Alzheimer's Day is dedicated to raising awareness of Alzheimer’s and other types of dementia, as well as challenging the stigma surrounding dementia. Read about some of our national member associations' many and varied campaigns and events.

Read more »
Rate: 12345 (0) | Facebook Twitter
27 September: Alzheimer Europe lunch debate focuses on AI and big data in dementia research

Alzheimer Europe held a lunch debate on 27 September in Brussels, focused on “The role of artificial intelligence and big data in dementia research”, attended by national member organisations, civil society representatives, industry partners, policy makers and members of the European Working Group of People with Dementia.

Read more »
Rate: 12345 (0) | Facebook Twitter
28 September: Eisai and Biogen announce postive trial results

On 28 September, Eisai and Biogen announced positive top-line results from a Phase III trial of lecanemab for the treatment of early Alzheimer’s disease. We welcome the encouraging data reported and look forward to hearing more at the upcoming Clinical Trials in Alzheimer’s Disease conference.

Read more »
Rate: 12345 (0) | Facebook Twitter
29 September: New European Working Group of People with Dementia confirmed for 2022-2024

EWGPWD squareWe are pleased to announce that the membership of the European Working Group of People with Dementia (EWGPWD) has been confirmed for the 2022-2024 term. The new group will officially begin its mandate after the upcoming Alzheimer Europe Conference, taking place from 17-19 October 2022.

Read more »
Rate: 12345 (0) | Facebook Twitter